The case was seen as a test of a more aggressive policy by the agency.
Related Posts
Merck KGaA’s Strategic $3.5 Billion Play: Acquiring SpringWorks to Revitalize Oncology Ambitions
In a move signaling renewed aggression in pharmaceutical M&A, Germany's Merck KGaA stands poised to finalize its largest therapeutic acquisition in a decade with the $3.5 billion purchase of...
Strategic Shifts in Pharma: Roche’s $50B U.S. Investment and the Looming Impact of Tariffs on M&A
As global trade tensions escalate under the Trump administration's tariff policies, Roche AG has emerged as a pivotal player in reshaping pharmaceutical manufacturing strategies. The Basel-based...
UPS Consolidates Healthcare Logistics Dominance With $1.6 Billion Andlauer Acquisition
In a strategic move that reshapes North America's healthcare logistics landscape, United Parcel Service (NYSE: UPS) announced today its definitive agreement to acquire Toronto-based Andlauer...
KKR’s $1.2 Billion Bet on Biotage: Reshaping the Life Sciences Tools Landscape
In a move signaling private equity's growing appetite for life sciences infrastructure, KKR & Co. launched a $1.2 billion cash offer for Swedish separations technology leader Biotage AB on April 22,...